Prospective-retrospective biomarker analysis for regulatory consideration: white paper from the industry pharmacogenomics working group. (Q45966834)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Prospective-retrospective biomarker analysis for regulatory consideration: white paper from the industry pharmacogenomics working group. |
scientific article |
Statements
Prospective-retrospective biomarker analysis for regulatory consideration: white paper from the industry pharmacogenomics working group (English)
Scott D Patterson
Nadine Cohen
Maha Karnoub
Sharada Louis Truter
Eileen Emison
Shirin Khambata-Ford
Brian Spear
Ekopimo Ibia
Rizwana Sproule
Diane Barnes
Anahita Bhathena
Michael R Bristow
Dai Wang
Amelia Warner
Agnes Westelinck
William Brian
Amir Snapir
Monique A Franc
Peggy Wong
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference